GALT — Galectin Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Galectin Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	27.1	39.6	18.6	25.7	15.1
Prepaid Expenses
Total Current Assets	29.5	41.8	20.6	27.7	17.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.048	0.007	0.086	0.053	0.016
Other Long Term Assets
Total Assets	29.6	41.8	21.3	28.2	17.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.4	9.03	13	15.7	35.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.41	39.2	53.5	88.4	121
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	24.2	2.62	-32.2	-60.2	-103
Total Liabilities & Shareholders' Equity	29.6	41.8	21.3	28.2	17.5
Total Common Shares Outstanding
Total Preferred Shares Outstanding